Icon plc Stock
Icon plc dominated the market today, gaining €14.46 (16.520%).
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Icon plc.
With a target price of 191 € there is a hugely positive potential of 92.0% for Icon plc compared to the current price of 99.48 €.
Pros and Cons of Icon plc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 16.520% | -10.819% | -0.251% | -31.017% | -43.504% | -49.963% | - |
| Alkermes plc | -0.380% | 0.704% | 13.492% | 17.213% | 21.186% | 12.598% | 54.595% |
| Ligand Pharmaceuticals | -1.510% | 1.015% | 19.880% | 108.377% | 19.880% | 184.286% | 59.200% |
| United Therapeutics | -0.560% | -0.634% | 6.975% | 89.478% | 13.784% | 132.632% | 186.000% |
Comments
Icon (ICLR) was upgraded by BMO Capital Markets from "market perform" to "outperform". They now have a $130.00 price target on the stock, up from $100.00.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat